1. GATE2BIOTECH 2007 International conference Brno, 17 October 2007 Alice Tomášková CZECHINVEST Deputy Chief of Executive

2. Biotechnology and Pharmacy  High growing sector with great future potential relating to elderly population  Development of infrastructure for biotechnologies - science incubators

3. Biotechnology and Pharmacy  Cluster activities  Development of bioinformatics  Research and development of new technologies and drugs

4. National and European Grants National Programmes (National Innovative Policy) - Program Innovation; Prosperity; Potential; Tandem etc. Investment incentives - Program for Support of Technology Centres and Business Support services Structural Funds - Operation programmes Research and Development for Innovation - Operation programme Business and Innovation - Operation programme Education for Competitiveness EU Grants: - Seventh Research Framework programme - E - Contentplus - Visegrad fund etc.

5. Biotech and Pharmacy Clusters in the Czech Republic PRAHA OSTRAVA BRNO AMR AMARANTH Aveflor Ferring Biotest Biopharm Biomedia Dekonta GeneAge Technologies Generi- Biotech Clonestar Favea Chemopharma Biovendor Contipro group Bioveta Ardeapharma Beckman Coulter - Immunotech Noventis Infusia Imunomedica Farmark Envisan-Gem Dyntec Dr. Bubeníček HERBACOS- BOFARMA Pliva - Lachema Olchemin Mediplast Medicom International Medicol IVAX Pharmaceuticals BaxterI.Q.AVidia Exbio Lonza Biotech

6. Role of CzechInvest Czech Republic has got a long tradition of research development and dispose of giant science potential ROLE OF CZECHINVEST IS TO BRING TOGETHER CZECH INTELLECTUAL POTENTIAL AND FOREIGN INVESTMENTS SUPPORTS HIGH ADDED VALUE PROJECTS

7. CzechInvest, the Investment and Business Development Agency, is an agency of the Ministry of Industry & Trade of the Czech Republic © Copyright, CzechInvest 2006. All rights reserved Thank you for your attention Alice Tomášková CzechInvest Deputy CEO Phone: +420 296 342 584 Fax: +420 296 342 502 Email: alice.tomaskova@czechinvest.org